Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix?
Hum Vaccin Immunother
.
2024 Dec 31;20(1):2300158.
doi: 10.1080/21645515.2023.2300158.
Epub 2024 Jan 29.
Authors
Paulo R Z Antas
1
2
,
Mario A Flores-Valdez
3
,
Camille Locht
4
Affiliations
1
Fundação Oswaldo Cruz, Fiocruz, Brazil.
2
Programa de Pós-graduação em Patologia, Universidade Federal do Ceará, Brazil.
3
Biotecnología Médica y Farmacéutica, Centro de Investigación y Asistencia en Tecnología y diseño del Estado de Jalisco, Mexico.
4
University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, France.
PMID:
38287731
PMCID:
PMC10829833
DOI:
10.1080/21645515.2023.2300158
No abstract available
Publication types
Editorial
MeSH terms
BCG Vaccine*
Humans
Immunization, Secondary
Mental Recall
Tuberculosis* / prevention & control
Substances
BCG Vaccine
Grants and funding
The author(s) reported that there is no funding associated with the work featured in this article.